Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Secondary Prophylaxis of GI Bleeding in Cirrhosis
NCT00787436Phase 3Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- May 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in Gastrointestinal Bleeding (GIB), sponsored by Cleveland Clinic. Planned start May 2006; status: withdrawn.
02
Drugs
thalidomide
03
Conditions
Gastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT00787436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00787436.